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Abstract: Age-related macular degeneration (AMD) is a retinal disease leading to impaired vision.
Cigarette smoke increases the risk for developing AMD by causing increased reactive oxygen species
(ROS) production and damage in the retinal pigment epithelium (RPE). We have previously shown
that the cigarette tar component hydroquinone causes oxidative stress in human RPE cells. In the
present study, we investigated the propensity of hydroquinone to induce the secretion of interleukin
(IL)-1β and IL-18. The activation of these cytokines is usually regulated by the Nucleotide-binding
domain, Leucine-rich repeat, and Pyrin domain 3 (NLRP3) inflammasome. ARPE-19 cells were
exposed to hydroquinone, and cell viability was monitored using the lactate dehydrogenase (LDH)
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide salt (MTT) assays. Enzyme-linked
immunosorbent assays (ELISAs) were used to measure the levels of proinflammatory cytokines IL-1β
and IL-18 as well as NLRP3, caspase-1, and poly (ADP-ribose) polymerase (PARP). Hydroquinone did
not change IL-1β release but significantly increased the secretion of IL-18. Cytoplasmic NLRP3 levels
increased after the hydroquinone treatment of IL-1α-primed RPE cells, but IL-18 was equally released
from primed and nonprimed cells. Hydroquinone reduced the intracellular levels of PARP, which
were restored by treatment with the ROS scavenger N-acetyl-cysteine (NAC). NAC concurrently
reduced the NLRP3 levels but had no effect on IL-18 release. In contrast, the NADPH oxidase inhibitor
ammonium pyrrolidinedithiocarbamate (APDC) reduced the release of IL-18 but had no effect on the
NLRP3 levels. Collectively, hydroquinone caused DNA damage seen as reduced intracellular PARP
levels and induced NLRP3-independent IL-18 secretion in human RPE cells.
Keywords: hydroquinone; oxidative stress; IL-1β; IL-18; NLRP3; RPE cell; PARP; DNA damage;
NAC; APDC
1. Introduction
Cigarette smoke is a risk factor of age-related macular degeneration (AMD) that
induces apoptosis, DNA damage, endoplasmic reticulum (ER) stress, mitochondrial frag-
mentation, reactive oxygen species (ROS) production and vascular endothelial growth
factor (VEGF) expression in retinal pigment epithelial (RPE) cells [1–5]. RPE cells main-
tain retinal homeostasis and support the functionality of photoreceptor cells, i.e., these
cells are essential for good vision [6–8]. AMD can develop either into a dry (85–90%)
or wet (10–15%) disease form [6,7]. The late forms of AMD manifest with a geographic
atrophy in dry AMD or with an exudative form in wet AMD [7,9,10]. RPE degeneration
and inflammation are involved in both disease forms [7,11,12]. RPE cell degeneration
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is a typical finding, especially in atrophic AMD, whereas choroidal neovascularization,
hemorrhages, and swelling of the retina are hallmarks of wet AMD [7,9,10]. Oxidative
stress and nucleotide-binding domain, leucine-rich repeat, and pyrin domain 3 (NLRP3)
inflammasome activation are fundamental in the pathogenesis of AMD [5,7,10,12–14].
Hydroquinone, a component included in cigarette smoke, induces oxidative stress but
prevents nuclear factor kappa B (NF-κB) activity and the release of interleukin (IL)-6 and
IL-8 cytokines from RPE cells [5,15–17]. Increased ROS production is a known activator of
NLRP3 inflammasome, leading to the cleavage and release of IL-1β with or without concur-
rent maturation of IL-18 in human RPE cells [14,18]. The NLRP3 receptor is a pattern recog-
nition receptor (PRR) that senses a wide variety of danger signals (pathogen or damage-
associated molecular patterns i.e., PAMPs or DAMPs, respectively) [12,19,20]. Along with
ROS production, its activation mechanisms include lysosomal destabilization and adeno-
sine triphosphate (ATP) release-associated purinergic receptor X7/P2X purinoceptor 7
(P2X7) activation, resulting in K+-efflux and Ca2+-influx [13,14,18,21–23]. NLRP3 inflam-
masome activation requires consecutive priming and activation signals [13,19,24]. The
priming signal, typically mediated through a Toll-like receptor (TLR) or a cytokine receptor,
leads to the expression of the NLRP3 protein as well as the proforms of IL-1β and caspase-
1 [13,25–27]. Epithelial cells tend to express pro-IL-18 continuously without priming [25,27].
An activation signal induces the assembly of NLRP3 inflammasome complex where pro-
caspase-1 becomes attached to oligomerised NLRP3 via the apoptosis-associated speck-like
protein containing a caspase-recruitment domain (ASC). The formation of this complex
results in caspase-1 activation and subsequent cleavage of IL-1β and IL-18 into their mature
and secreted forms [12,19,20,28]. IL-1β is involved in inflammatory diseases but it also
possesses angiogenic properties [29–31]. IL-18 is a pleiotropic cytokine with distinct effects
in different AMD models [32,33]. In mice, it has been observed to be protective against
tuberculosis but harmful in combatting Ehrlichia infection [34,35].
In this study, we investigated the propensity of hydroquinone to activate NLRP3
inflammasome signaling in human RPE cells since we have previously shown that hydro-
quinone can induce ROS production in ARPE-19 cells, and oxidative stress is one of the
best-known mechanisms of NLRP3 inflammasome activation [14,15,18]. Our results show
that in addition to DNA damage, hydroquinone induced both NLRP3 inflammasome and
IL-1α priming-independent secretion of IL-18 in human ARPE-19 cells.
2. Materials and Methods
2.1. Cell Culture and Treatments
Experiments were performed using ARPE-19 cells (ATCC) that were cultured in
DMEM/F12 (1:1) medium (Life Technologies, Paisley, UK) with added 10% fetal bovine
serum (GE Healthcare Life Sciences, South Logan, UT, USA), penicillin 100 U/mL, strepto-
mycin 100 µg/mL (Pen Strep, Life Technologies, Grand Island, NY, USA), and L-glutamine
2 mM (Life Technologies, Paisley, UK). The experiments were conducted in the same
medium without serum supplement, and L-glutamine was added separately in each inde-
pendent experiment just prior to the IL-1α-priming. Hydroquinone was dissolved in the
medium before each experiment.
In the experiments, cells were seeded onto 12-well plates (Costar, Corning Inc., Ken-
nebunk, ME, USA) at the density of 200,000 cells per well and incubated for three days at
+37 ◦C under 5% CO2. The cells were first washed once using serum-free medium and then
primed using recombinant human IL-1α (4 ng/mL, R&D Systems, Minneapolis, MN, USA)
for 24 h at +37 ◦C and 5% CO2. Thereafter, the cells were washed once again with medium
and exposed to hydroquinone (HQ, 10 µM to 500 µM; Sigma-Aldrich, Saint Louis, MO,
USA) for 18 h at +37 ◦C and 5% CO2. After the treatments, medium samples were collected
and centrifuged at 381× g and +4 ◦C for 10 min (Biofuge Fresco Heraeus Instruments, New-
port Pagnell, UK). Cells were either used directly for a viability assay or collected and lysed
for other analyses. Optimal hydroquinone concentrations were probed by exposing cells to
10–500 µM hydroquinone, and cell viability and the secretion of mature IL-1β and IL-18
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were determined. Two hydroquinone concentrations, 10 µM and 200 µM, were selected for
the subsequent NLRP3 assays using only 200 µM for ATP and caspase-1 measurements.
Caspase-1 inhibitor (casp.-1 inhib.; 20 µM in DMSO 0.22% v/v, Ac-YVAD-cmk, Sigma, St.
Louis, MO, USA) was added 1 h before hydroquinone exposure when the role of caspase-1
in IL-18 release was investigated. Hydroquinone (200 µM) was also tested on unprimed
cells. In experiments of NLRP3 silencing, ARPE-19 cells were seeded onto 12-well plates
at the density of 150,000 cells per well and incubated for 24 h at +37 ◦C and 5% CO2.
Cells were washed once with DMEM/F12 medium without serum and antibiotics, and
500 µL of the same medium was added into each well. Cells were transfected by adding
lipofectamine (lipofectamine RNAiMAX/lipofectamine 2000, Invitrogen by Thermo Life
Technologies Corp., Carlsbad, CA, USA) with NLRP3 siRNA (siNLRP3 10 pmol; NLRP3
Silencer select predesigned siRNA, id:s41556, Ambion, Austin, TX, USA) diluted in Opti-
MEM medium (Thermo Fisher Scientific, Grand Island, NY, USA) for 24 h at +37 ◦C and
5% CO2. Negative siRNA (Silencer select Negative control #1 siRNA, Ambion, Austin, TX,
USA) and transfection reagent (Tr. reag.; Opti-MEM with lipofectamine) without siRNAs
served as controls. After transfection, cells were washed, primed with IL-1α, and exposed
to 200 µM hydroquinone, as described above. The effects of siNLRP3 transfection on the
release of IL-18 and lactate dehydrogenase (LDH) were determined.
When determining the effects of antioxidants, cells were primed with IL-1α for 24 h at
+37 ◦C and 5% CO2, washed, and exposed to the NADPH oxidase inhibitor ammonium
pyrrolidinedithiocarbamate (APDC, 2 µM; Sigma-Aldrich, St. Louis, MO, USA) for 5 min, or
to the ROS scavenger N-acetyl-cysteine (NAC, 5 mM; Sigma-Aldrich, St. Louis, MO, USA)
for 1 h as in our previous investigation of hydroquinone-mediated ROS production [15].
Thereafter, 200 µM hydroquinone was added for an additional 18 h. Untreated and IL-1α-
primed cells served as controls.
2.2. Cell Viability Assays
Before sample collection, the cells were visually observed and photographed us-
ing an Axio Vert A1 Zeiss microscope with AxioCam MRm camera and Zen 2011 pro-
gram (Carl Zeiss Microscopy GmbH, Jena, Germany). Thereafter, half (500 µL) of the cell
culture medium was collected and centrifuged, as described above. LDH release was
measured from medium samples immediately after the collection using the CytoTox96®
Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI, USA) according to the man-
ufacturer’s instructions. Absorbance values were measured at a wavelength of 490 nm
with a spectrophotometer BioTek, ELx808 and the Gen-5 2.04 program (Instruments Inc.,
Winooski, VT, USA).
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide salt (MTT; 0.5 mg/mL,
Sigma-Aldrich, St. Louis, MO, USA) was added to cells remained on 12-well culture plates
in the rest of medium (500 µL) and incubated for 3 h in the dark at +37 ◦C and 5% CO2, as
described previously [15]. Absorbance values were measured at the wavelength of 560 nm
using the spectrophotometer BioTek, ELx808.
2.3. Enzyme-Linked Immunosorbent Assay
The enzyme-linked immunosorbent assay (ELISA) technique was used to determine
the levels of active IL-1β and IL-18, intra- and extracellular NLRP3, as well as cleaved
caspase-1 (p20) and poly (ADP-ribose) polymerase (PARP) levels. IL-1β, IL-18, NLRP3,
and caspase-1 were measured using the IL-1β BD OptEIATM Human ELISA Kit (BD Bio-
sciences, San Diego, CA, USA), the Human IL-18 ELISA kit (Invitrogen by Thermo Fisher
Scientific, Vienna, Austria), the Human NACHT, LRR and PYD domains-containing protein
3 (NLRP3/c1orf7/CIAS1/NALP3/PYPAF1) ELISA kit (Cusabio Biotech co., LTD, Wuhan,
Hubei Province, China), and the Quantikine ELISA Human caspase-1/ICE immunoassay
(R&D systems, McKinley, MN, USA), respectively. Absorbance values were determined at
the wavelength of 450 nm with the correction wavelength of 655 nm in a spectrophotometer
(Bio-Rad Model 550 with the Microplate Manager 5.2 program, Bio-Rad Laboratories Inc.,
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Hercules, CA, USA). DNA damage was determined by measuring the PARP levels with
the PARP/Apoptosis Colorimetric Assay Kit (R&D Systems, Minneapolis, MN, USA) and
detecting absorbance values at the wavelength of 450 nm using a microplate reader Bio-Rad
Model 550.
For the detection of intracellular NLRP3, cells were lysed with 40 µL of 1× lysis
buffer (Cell Lysis Buffer 10×, Cell Signaling Technology, Leiden, Netherlands) in a tube
containing cells from one well of a 12-well plate and incubated on ice for 5 min. Thereafter,
the lysates were sonicated (3 × 10 s) and centrifuged at 16,090× g and +4 ◦C for 10 min.
Supernatants were moved into clean microtubes and their protein concentrations were
measured utilizing a protocol based on the Bradford method [36]. Briefly, the bovine serum
albumin fraction V (BSA 1 mg/mL; Roche, Mannheim, Germany) was used to create a
standard curve (0.5–3.5 µg/µL). Thereafter, samples were pipetted (0.5–3.5 µL) into wells
of a 96-well plate, Bradford solution (200 µL) was added to all wells, and absorbance values
were measured at the wavelength of 595 nm in a spectrophotometer Bio-Rad Model 550.
NLRP3 levels were determined from remaining cell lysate using the ELISA technique with
the results normalized to the protein level of the respective sample.
When measuring the levels of cleaved caspase-1, cells were lysed using the RIPA
buffer (Thermo Scientific, Rockford, IL, USA), incubated for 5 min on ice, and centrifuged
at 16,090× g and +4 ◦C for 10 min. The Pierce bicinchoninic acid (BCA) protein Assay Kit
(Thermo Scientific, Rockford, IL, USA) was used to measure protein concentrations, and
15 or 25 µg of protein from each sample was used for the ELISA analysis.
When measuring the PARP levels, cells were lysed according to the manufacturer’s
protocol, and the Pierce BCA protein assay was used to determine protein levels. Thereafter,
5 µg of protein from sample was used for the ELISA assay.
2.4. Extracellular ATP
The levels of ATP in culture medium were measured using the CellTiter-Glo Lumi-
nescent Cell Viability Assay (Promega, Madison, WI, USA) following the manufacturer’s
instructions. Luminescence values were measured using the BioTek Cytation3 imaging
reader with the Gen-5 3.03 program (Instruments Inc., Winooski, VT, USA).
2.5. Statistical Analyses
Results were analyzed using the GraphPad Prism program 7.04 (Graphpad Software,
San Diego, CA, USA). Normality was determined using the Shapiro-Wilk and D’Agostino
& Pearson normality tests (data not presented). Statistical differences between all groups
were determined with the Kruskal-Wallis test, and post hoc comparisons using the Mann-
Whitney U-test. Results are shown as mean ± standard error of mean (SEM) and differences
were considered as statistically significant with p-values below 0.05.
3. Results
3.1. Hydroquinone Induces IL-18 Secretion in ARPE-19 Cells
Hydroquinone induces ROS production and cytotoxicity concentration-dependently
in human ARPE-19 cells [15–17]. In order to investigate whether hydroquinone could
induce the secretion of proinflammatory cytokines, IL-1β and IL-18, we determined their
extracellular levels as well as their correlation with cell viability after an exposure of IL-1α-
primed ARPE-19 cells to different hydroquinone concentrations ranging from 10 µM to
500 µM. Low hydroquinone concentrations (10–50 µM) were well tolerated by RPE cells
since LDH release and MTT values remained unchanged when compared to IL-1α-primed
ARPE-19 cells without hydroquinone (Figure 1). LDH release was significantly increased
in cells exposed to at least 100 µM hydroquinone, while metabolic activity was significantly
reduced when the hydroquinone concentration was 150 µM or higher (Figure 1).
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Figure 1. The effect of hydroquinone (HQ 10–500 µM; 18 h) on the cell viability of IL-1α-primed ARPE-19 cells measured
using the LDH (A) and MTT (B) assays. Results have been normalized to the mean of the untreated control group. IL-1α-
treated cells served as a control for hydroquinone exposure in primed cells. Data were combined from three independent
experiments with four parallel samples per group. Results are shown as mean ± SEM. **** p < 0.0001, ns—not significant,
Mann-Whitney U-test.
Next, we measured the production of proinflammatory cytokines IL-1β and IL-18
from IL-1α-pri ed ARPE-19 cells in response to hydroquinone exposure (Figure 2). Hy-
droquinone had no additional effect on the IL-1β release, which remained at the same level
as in IL-1α-treated cells (Figure 2A). Hydroquinone induced significant secretion of IL-18
at the 200 µM and 300 µM concentrations, whereas lower (≤150 µM) or higher (500 µM)
concentrations had no effect on the IL-18 levels (Figure 2B).
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from IL-1α-primed ARPE-19 cells. Data were combined from three independent experiments with
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*** p < 0.001, **** p < 0.0001, ns—not significant, Mann-Whitney U-test. [Kruskal-Wallis test, (A) ns
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3.2. Hydroquinone Increases the Intracellular Level of NLRP3 in IL-1α-Primed ARPE-19 Cells
We showed previously that the oxidative stress induced either by impaired protein
clearance or 4-hydroxynonenal (HNE) exposure promoted NLRP3 inflammasome sig-
naling with caspase-1 activation in RPE cells favoring the secretion of IL-1β or IL-18,
respectively [14,18]. In the present study, we investigated whether hydroquinone pro-
moted NLRP3 inflammasome activation in human ARPE-19 cells. We have also showed
that NLRP3 is partially degraded, but also secreted, out of the cells after the activation of
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the inflammasome [37,38]. In the present study, IL-1α alone resulted in 2.8 and 43.9-fold
intra- and extracellular NLRP3 levels, respectively, when compared to untreated control
cells (Figure 3). Hydroquinone at the 10 µM concentration had no additional effect on
the intra- or extracellular levels of NLRP3 when compared to IL-1α-treated cells without
hydroquinone (Figure 3). In contrast, hydroquinone at the 200 µM concentration signifi-
cantly elevated the levels of intracellular NLRP3, while the extracellular levels of NLRP3
remained significantly lower (Figure 3). In conclusion, we did not detect any evidence of
the release of NLRP3 at the 200 µM hydroquinone concentration where the production of
IL-18 peaked (Figure 2).
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Figure 3. The effect of hydroquinone (HQ 10 µM, 200 µM; 18 h) on the levels of NLRP3 in cell lysate
(A) and medium (B) samples in IL-1α-primed ARPE-19 cell cultures. Results (A) were normalized to
the total protein level. Absorbance valu s in (A) were 0.263–0.507 in the control, 0.548–1.516 in the
IL-1α, 0.416–0.862 in the IL-1α + HQ 10 µM, and 4.492–9.375 in the IL-1α + HQ 200 µM group. NLRP3
concentrations in medium samples (B) were 0.590–2.054 ng/mL in the control, 11.81–161.453 ng/mL
in the IL-1α, 10.345–28.244 ng/mL in the IL-1α + HQ 10 µM, and 1.268–6.303 ng/mL in the IL-1α +
HQ 200 µM group. Data were combined from three independent experiments with two (A) or three
(B) parallel samples per group in each experiment. Results are shown as mean ± SEM. *** p < 0.001,
**** p < 0.0001, ns—not significant, Mann-Whitney U-test.
3.3. Hydroquinone Exposure Does Not Induce Caspase-1 Activation in ARPE-19 Cells
Next, we investigated whether caspase-1 would be activ ed n ontributes to he
secretion of IL-18 upon hydroquin e exposure in IL-1α-primed RPE cells. Similarly to the
situation with NLRP3, we previously observed that cleaved caspase-1 is partially released
from the cell upon inflammasome activation [37,39]. IL-1α did not increase the intracellular
levels of cleaved caspase-1 (p20) when compared to the untreated control cells (Figure 4A).
Hydroquinone reduced the caspase-1 (p20) levels in cell lysate samples of IL-1α-primed
ARPE-19 cells when compared to the primed cells without hydroquinone (Figure 4A).
Cleaved caspase-1 was not detected in medium samples of controls or hydroquinone-
treated cells. Absorbance values were 0.182–0.197 in the control, 0.193–0.204 in the IL-1α,
and 0.182–0.193 in the 200 µM hydroquinone group of IL-1α-primed cells. Caspase-1 in-
hibitor had no effect on the IL-18 release (Figure 4B). These data suggest that hydroquinone
did not activate caspase-1 in human ARPE-19 cells.
3.4. Hydroquinone Does Not Need Priming or NLRP3 Inflammasome Activation to Induce
IL-18 Release
We have showed previously that UVB irradiation-induced IL-1β secretion was NLRP3-
dependent, but this was not the case for IL-18 release [39]. Next, we examined whether
hydroquinone alone would be capable of inducing the release of IL-18 without IL-1α-
priming. Hydroquinone significantly increased IL-18 secretion but the levels of intra-
cellular NLRP3 remained at the levels of untreated control cells (Figure 5). In order to
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confirm the NLRP3-independent IL-18 release, cells were treated with siNLRP3 before the
hydroquinone exposure of IL-1α-primed cells. Specific NLRP3 siRNA did not reduce IL-18
release when compared to hydroquinone with transfection reagent without siNLRP3 in
IL-1α-primed cells (Figure 6). These findings support the data shown above that hydro-
quinone was able to induce IL-18 secretion from ARPE-19 cells without the activation of
NLRP3 inflammasome.
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Figure 5. The effect of 200 µM hydroquinone (HQ; 18 h) on the IL-18 secretion (A) and on the intracel-
lular NLRP3 level (B) in unprimed ARPE-19 cells. An untreated control group was used as the control
for hydroquinone treatment. IL-18 concentratio s in medium samples (A) were 4.552–10.556 pg/mL
in the control and 32.132–123.617 pg/mL in the HQ 200 µM group. Absorbance values in (B) were
0.443–0.563 in the control and 0.345–0.579 in the HQ 200 µM group. Data were combined from two
independent experiments containing four (A) or two (B) parallel samples per group. Results are
shown as mean ± SEM. *** p < 0.001, ns—not significant, Mann-Whitney U-test.
3.5. APDC Reduces the Release of IL-18 But Not NLRP3, While NAC Has the Opposite Effect
upon Hydroquinone Exposure of IL-1α-Primed ARPE-19 Cells
We showed previously that both NAC and APDC are able to reduce hydroquinone-
induced ROS production in RPE cells [15]. Since it is known that IL-18 release from
UVB-treated ARPE-19 cells is ROS-dependent [39], we tested whether antioxidants APDC
or NAC would exert any effect on RPE cells exposed to hydroquinone. APDC had no
effect on the LDH release, but NAC reduced it when compared to primed RPE cells
after hydroquinone exposure without the supplementation with antioxidants (Figure 7).
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Microscope observations were in line with the LDH data since APDC-treated cells were
damaged, but the NAC-treated cells appeared healthy and viable (Figure 8). APDC
reduced the secretion of IL-18 but did not affect the intracellular NLRP3 levels (Figure 7). In
contrast, NAC had no effect on the levels of IL-18 in IL-1α-primed ARPE-19 cells exposed
to hydroquinone, but the levels of NLRP3 as a part of the total protein concentration
were significantly lower when compared to the respective cells without NAC (Figure 7).
These results suggest that the release of IL-18 and the expression of NLRP3 protein are not
dependent on each other in the cells’ response to hydroquinone exposure.




Figure 5. The effect of 200 μM hydroquinone (HQ; 18 h) on the IL-18 secretion (A) and on the intracellular NLRP3 level 
(B) in unprimed ARPE-19 cells. An untreated control group was used as the control for hydroquinone treatment. IL-18 
concentrations in medium samples (A) were 4.552–10.556 pg/mL in the control and 32.132–123.617 pg/mL in the HQ 200 
μM group. Absorbance values in (B) were 0.443–0.563 in the control and 0.345–0.579 in the HQ 200 μM group. Data were 
combined from two independent exp riments containing four (A) or two (B) parallel samples per g oup. Results are 
shown as mean ± SEM. *** P < 0.001, ns—not significant, Mann-Whitney U-test. 
 
Figure 6. The effect of siNLRP3 on the hydroquinone-induced (HQ 200 μM; 18 h) release of IL-18 
(A) and LDH (B) in IL-1α-primed ARPE-19 cells. Transfection reagent without siRNAs (Tr. reag.) 
was used as a control for the siNLRP3 treatment and negative siRNA (Neg. siRNA) was used to 
indicate if unspecific reduce of IL-18 release was detected. IL-18 concentrations in (A) were 1.342–
8.686 pg/mL in the IL-1α, 4.267–11.166 pg/mL in the Tr. reag. + IL-1α + HQ 200 μM, 10.187–12.171 
pg/mL in the neg. siRNA + IL-1α + HQ 200 μM, and 6.233–12.171 pg/mL in the siNLRP3 + IL-1α + 
HQ 200 μM group. Data were combined from two independent experiments with four parallel 
samples per group in each experiment. Results are shown as mean ± SEM. * P < 0.05, *** P < 0.001, 
ns—not significant, Mann-Whitney U-test. [Kruskal-Wallis test, (A) *** P < 0.001, (B) *** P < 0.001]. 
3.5. APDC Reduces the Release of IL-18 but not NLRP3, while NAC has the Opposite Effect 
upon Hydroquinone Exposure of IL-1α-primed ARPE-19 Cells 
We showed previously that both NAC and APDC are able to reduce hydroquinone-
induced ROS production in RPE cells [15]. Since it is known that IL-18 release from UVB-
treated ARPE-19 cells is ROS-dependent [39], we tested whether antioxidants APDC or 
NAC would exert any effect on RPE cells exposed to hydroquinone. APDC had no effect 
Figure 6. The effect of siNLRP3 on the hydroquinone-induced (HQ 200 µM; 18 h) release of IL-18 (A)
and LDH (B) in IL-1α-primed ARPE-19 cells. Transfection reagent without siRNAs (Tr. reag.) was
used as a control f siNLRP3 treatment a d negative siRNA (Neg. siRNA) was used to indicate if
unspecific reduce of IL-18 release was detected. IL-18 concentrations in (A) were 1.342–8.686 pg/mL
in the IL-1α, 4.267–11.166 pg/mL in the Tr. reag. + IL-1α + HQ 200 µM, 10.187–12.171 pg/mL in the
neg. siRNA + IL-1α + HQ 200 µM, and 6.233–12.171 pg/mL in the siNLRP3 + IL-1α + HQ 200 µM
group. Data were combined from two independent experiments with four parallel samples per group
in each experiment. Results are shown as mean ± SEM. * p < 0.05, *** p < 0.001, ns—not significant,
Mann-Whitney U-test. [Kruskal-Wallis test, (A) *** p < 0.001, (B) *** p < 0.001].
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Figure 7. The effect of antioxidants (2 µM APDC, 5 mM NAC) in conjunction with 200 µM hydroquinone
(HQ; 18 h) on the release of LDH (A) and IL-18 (B), and on the intracellular NLRP3 (C) levels in IL-1α-
primed ARPE-19 cells. Data were combin d from f ur (A,B) r 2 (C) independent exp riments containing
four (A, B) or two (C) parallel samples per group. IL-18 concentrations in (B) were 0.745–10.597 pg/mL
in the IL-1α, 6.515–83.423 pg/mL in the IL-1α + HQ 200 µM, 2.58–26.253 pg/mL in the IL-1α + APDC +
HQ 200 µM, and 7.721 6.506 pg/mL in the IL-1α + NAC + HQ 200 µM group. Absorb ce values in
(C) were 0.62–0.72 in the control, 2.171–2.824 in the IL-1α + HQ 200 µM, 1.816–2.564 in the IL-1α + APDC
+ HQ 200 µM, and 1.266–2.25 in the IL-1α + NAC + HQ 200 µM group. Results are presented as mean ±
SEM. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns = not significant, Mann-Whitney U-test.
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Figure 8. The effect of 200 µM hydroquinone (HQ; 18 h) on ARPE-19 cells with and without IL-1α-
priming and antioxidants (2 µM APDC, 5 mM NAC). Cells were visualized using the Axio Vert A1
Zeiss microscope with AxioCam MRm camera and Zen 2011 program (Carl Zeiss Microscopy GmbH,
Jena, Germany).
3.6. Hydroquinone Increases the Levels of Extracellular ATP
Extracellular ATP is reported to be one potential activator of the NLRP3 inflammasome
with the effect mediated through the P2X7 receptor, but it can also serve as a secondary
response to NLRP3 activation as well as a stimulant for the antioxidant system in times
of oxidative stress [18,23,40]. In order to study the potential role of ATP, we measured
the extracellular ATP levels after the IL-1α-primed cells were exposed to hydroquinone.
Hydroquinone increased the extracellular ATP levels concurrently while elevating the
intracellular level of NLRP3 and the amount of IL-18 from IL-1α-primed ARPE-19 cells
(Figure 9). IL-1α treatment reduced the extracellular ATP levels in ARPE-19 cell cultures,
whereas hydroquinone at 200 µM concentration significantly increased the extracellular
ATP levels in IL-1α-primed cells (Figure 9).
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Figure 10. The effect of 200 µM hydroquinone (HQ) on the intracellular PARP level with and without
IL-1α-priming and antioxidants (2 µM APDC, 5 mM NAC) in ARPE-19 cells. IL-1α and untreated
control group were used as the control for hydroquinone treatment. Data were collected from two
independent experiments containing three parallel samples per group. Results are shown as mean ±
SEM. ** p < 0.01, Mann-Whitney U-test.
4. Discussion
AMD is a consequence of RPE cell degeneration that causes photoreceptor cell death
and impaired vision [7]. Oxidative stress, a major factor in the pathogenesis of both dry
and wet AMD, is a potent activator of the NLRP3 inflammasome in RPE cells [7,12–14,18].
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Hydroquinone is a genotoxic and cytotoxic compound that induces ROS production in
RPE cells [15–17,42–44]. However, hydroquinone is sensitive to any kind of variation in
experimental conditions, such as changes in diluent or medium supplements, which can
influence the concentration needed to evoke cytotoxicity [16,17,43,45]. In the present study,
signs of cellular membrane rupturing and reduced metabolic activity were evident in IL-1α-
primed human RPE cells when the hydroquinone concentrations were greater than 100 µM
and 150 µM, respectively. In our previous experiments with ARPE-19 cells without priming,
the corresponding hydroquinone concentrations were 125 µM and 200 µM [15]. Thus, our
data suggest that if ARPE-19 cells are exposed to the proinflammatory IL-1α cytokine,
this makes them more sensitive to the adverse effects of hydroquinone. This finding
is in line with the observation that treatment with an IL-1 receptor antagonist reduced
hydroquinone-induced apoptosis in keratinocytes by preventing IL-1α activity [46].
NLRP3 inflammasome activation with subsequent caspase-1 activation is known to re-
sult in the cleavage of pro-IL-1β and pro-IL-18 into their mature and secreted
forms [12,19,20,28]. However, NLRP3 inflammasome activation does not always lead
to the secretion of both cytokines [33,39,47]. The accumulation of Alu RNA has been shown
to induce IL-18 but not IL-1β release from RPE cells [33]. The outcome in ARPE-19 cells,
especially of IL-18 production, appears to be highly context-dependent. HNE induced the
secretion of both cytokines but impaired protein clearance favored IL-1β secretion with
undetectable IL-18 levels [14,47]. Upon exposure to UVB, the same cell cultures produced
both cytokines but only IL-1β was NLRP3 inflammasome-dependent [39]. The present
study revealed one more difference i.e., hydroquinone induced IL-18 secretion but had
no effect on the production of IL-1β in IL-1α-primed ARPE-19 cells. The propensity of
hydroquinone to promote IL-18 production has also been observed in a mouse model
of contact hypersensitivity [48], which supports the concept that the regulation of IL-18
release strongly depends on the activation signal and may not be as strictly inflammasome-
dependent as is the case for IL-1β.
In our previous study, where UVB induced an NLRP3 inflammasome-independent
release of IL-18, we observed that it was ROS that were responsible for the release of the
cytokine [39]. We wished to examine another DNA-damaging factor and, therefore, we
studied hydroquinone. We observed that APDC, but not NAC, reduced IL-18 secretion
after the cells were exposed to hydroquinone. We previously showed that both the NADPH
oxidase inhibitor APDC and the ROS scavenger NAC can reduce ROS production induced
by hydroquinone in RPE cells [15]. The present data suggest that NADPH oxidase could
contribute to the IL-18 production evoked by hydroquinone exposure. However, since NAC
treatment exerted no response in RPE cells, APDC probably prevented IL-18 release by
some other mechanism and not by inhibiting NADPH oxidase-mediated ROS production.
Extracellular ATP can protect cells from DNA damage caused by chemical exposure;
it mediates this effect by activating P2X7 receptors, leading to NADPH oxidase-mediated
activation of caspase-4 and 5 [42,44,49,50]. In human intestinal endothelial cells, caspase-4
has been shown to increase mature form of IL-18 in response to an exposure to enteric
pathogens [51]. Our results are line with the concept that the ATP-induced NADPH oxidase
mediated caspase-4 or 5 activation could contribute to the production of IL-18, since along
with increased IL-18 production, hydroquinone resulted in significant ATP release from
RPE cells. In addition, the ability of ATP release to alleviate DNA damage would be
compatible with this concept since hydroquinone reduced the PARP levels in RPE cells.
PARP participates in the DNA damage repair response and induces poly (ADP-ribose)
(PAR) production-related DNA repair [52]. Hydroquinone has been shown to induce DNA
damage in human hepatoma HepG2 and TK6 lymphoblastoid cells [42,53,54]. In the latter
cells, the extent of the DNA damage correlated with immediately reduced PARP levels as
well as with increased PAR production [42].
In this study, we investigated the potential of hydroquinone exposure to induce NLRP3
inflammasome activation in ARPE-19 cells. Hydroquinone induced DNA damage and
promoted IL-18 secretion, which was independent from the NLRP3 inflammasome. Since IL-
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18 has been reported to reduce DNA damage in UVB-irradiated mouse keratinocytes [55,56],
the present results do not exclude the probability that the release of both ATP and IL-18
in response to hydroquinone exposure would be attempts by the human RPE cells to
alleviate hydroquinone-induced DNA damage. That proposal will need to be examined in
further studies.
5. Conclusions
Hydroquinone induced DNA damage and promoted an NLRP3-independent IL-18
release from RPE cells. NADPH oxidase contributed to IL-18 release but the detailed
mechanism still needs clarification.
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